Dr Sally Baron-Hay
FRACP MBBS, Medical Oncologist
A diagnosis of cancer is life changing and my role is to guide my patients through their journey with confidence and empathy. It is a privilege to be trusted with this task
Clinical interests in breast cancer and gynaecological malignancies.
Sally Baron-Hay, MBBS FRACP is a medical oncologist with over 20 years of clinical experience and senior lecturer at the University of Sydney, with clinical appointments at Royal North Shore Hospital in Sydney, North Shore Private Hospital, The Mater Hospital and Genesis Care.
She completed her undergraduate training at the University Western Australia and Sir Charles Gairdner Hospital before travelling to the UK to work in the Breast and Gynaeoncology Units at the Royal Marsden Cancer Centre, South Kensington, London where she developed her interest in translational oncology clinical trials. She completed her medical oncology training at RNSH, St. Leonards, and Royal Prince Alfred Hospital, Camperdown. Her basic research at the Kolling Institute, St Leonards investigated the role of Insulin Like Growth Factors in the pathogenesis and progression of Epithelial Ovarian Cancer. She received a NHMRC Scholarship and won the AACR Young Cancer Investigator award for this research.
Sally is interested in clinical research into breast and gynaecological malignancies. Sally sits on the Ovarian Cancer working tumour group within the Australian New Zealand Gynae Oncology Group. She has an interest in developing guidelines for the safe follow up and care for patients both during and following their cancer treatment.
She is a supervisor and mentor for Advanced Medical Oncology Trainees through the Royal Australasian College of Physicians undertaking their training at RNSH and educating medical students in the medical oncology discipline. She sits on the eviQ Medical Oncology Reference Committee for Breast and Gynaeoncology treatment protocols.
Sally's clinical interests now focus on the clinical management and improvement in outcomes for women with Breast and Gynaecological malignancies, through the identification of personalised new treatments.
- Translation clinical trials
- Improving models of care and implementing in the clinic